Meharry HIV/AIDS Research and Training Facility

梅哈里艾滋病毒/艾滋病研究和培训设施

• 批准号: 10547968
• 负责人: Vladimir Berthaud
• 金额: $ 200万
• 依托单位: MEHARRY MEDICAL COLLEGE
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-16 至 2027-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10547968
• 关键词: AIDS/HIV problem; Academic Medical Centers; Acquired Immunodeficiency Syndrome; Address; Adult; Area; Basic Science; Black race; Black, Indigenous, People of Color; COVID-19 pandemic; COVID-19 vaccine; Charge; Childhood; Clinic; Clinical Research; Clinical Trials; Collaborations; Communities; County; Development; Environment; Faculty; Floor; Goals; Grant; HIV; Health; Health Disparities Research; Health Professional; Health Sciences; Laboratories; Minority Groups; Mission; Modernization; Physicians; Play; Privatization; Research; Research Personnel; Research Training; Role; Site; Students; Tennessee; Testing; Training; Translational Research; Underrepresented Minority; Underserved Population; United States National Institutes of Health; Wellness Center; biomedical scientist; health inequalities; laboratory facility; medical schools; minority communities; minority scientist; operation; physical separation; programs

Project Summary The goal of the proposed HIV/AIDS Research and Training Facility grant is to renovate and develop the a cutting-edge and modern HIV research space at the Meharry Medical College (MMC). Meharry is one of the nation's oldest and largest private, historically Black academic health sciences centers. Since 1876, Meharry has been dedicated in educating healthcare professionals and biomedical scientists with a singular mission of addressing health inequities of underserved populations. For instance, MMC is playing a vital role in combatting the COVID-19 pandemic by spearheading the operations of the testing sites in Nashville and Davidson County in Tennessee (TN). MMC also conducted the adult and pediatric clinical trials of COVID-19 vaccines in minority populations. Importantly, the Meharry Center for AIDS Health Disparities Research (CAHDR), established in 2005 through NIH support, has been a leader in HIV/AIDS research and training of minority scientists, physicians, students, fellows and trainees. The scientific focus of the CAHDR is to identify, understand, and eliminate factors responsible for the profoundly disproportionate burden of HIV/AIDS among minority populations. The Center is charged to reduce the burden of AIDS in local minority communities through basic, clinical, and translational research. The HIV/AIDS-focused research environment at MMC has also been facilitated by the Meharry AIDS Center of Excellence clinic at the Meharry Community Wellness Center (MCWC). Both the CAHDR and MCWC are part of the TN Center for AIDS Research (TN-CFAR), a multi-institutional collaborative center involving Vanderbilt University Medical Center (VUMC), MMC, the TN Department of Health and Nashville CARES. Additionally, our HIV/AIDS research and training environment is also enriched by our long-standing partnership with VUMC through the Meharry Vanderbilt Alliance (MVA). Therefore, the proposed HIV/AIDS Research and Training Facility will allow us to further leverage our existing partnerships to emerge as a global leader in HIV/AIDS health disparities research and training. Currently, there are only four laboratories that are physically located within the CAHDR and several other HIV/AIDS investigators are housed in other buildings. This physical separation between our HIV/AIDS investigators poses barriers for interaction, training, access, and collaboration. Furthermore, our current lack of modern and cutting-edge laboratory space and facility severely impedes our ability to attract new faculty to the CAHDR. To address these gaps, this proposal outlines the development of cutting-edge HIV/AIDS laboratory facility adjacent to the CAHDR that will include space for four to six new investigators in an open lab space format. Together, this renovation proposal will provide unprecedented opportunity to bring all Meharry HIV/AIDS researchers to the CAHDR Floor and expand our HIV/AIDS research program into cutting-edge new areas. Most importantly, a modern and cutting-edge HIV research space will allow us to prepare and increase the number of underrepresented minority (URM) and Black, Indigenous, and People of Color (BIPOC) researchers participating in HIV-focused research.

项目概要 拟议的艾滋病毒/艾滋病研究和培训基金赠款的目标是翻新和发展 梅哈里医学院 (MMC) 的尖端现代艾滋病毒研究空间。梅哈里就是其中之一 全国最古老、最大的私立、历史悠久的黑人学术健康科学中心。自 1876 年以来，梅哈里 致力于教育医疗保健专业人员和生物医学科学家，其独特使命是 解决服务不足人群的健康不平等问题。例如，MMC在对抗战争中发挥着至关重要的作用。 通过带头运营纳什维尔和戴维森县的检测点来应对 COVID-19 大流行 在田纳西州（TN）。 MMC还在少数群体中开展了COVID-19疫苗的成人和儿童临床试验 人口。重要的是，梅哈里艾滋病健康差异研究中心 (CAHDR) 成立于 2005年通过NIH的支持，一直是艾滋病毒/艾滋病研究和少数族裔科学家、医生培训领域的领导者， 学生、研究员和实习生。 CAHDR 的科学重点是识别、理解和消除因素 少数群体人口中艾滋病毒/艾滋病造成的严重负担负有责任。该中心是 致力于通过基础、临床和转化来减轻当地少数民族社区的艾滋病负担 研究。梅哈里艾滋病研究中心也促进了 MMC 以艾滋病毒/艾滋病为重点的研究环境 梅哈里社区健康中心 (MCWC) 的卓越中心诊所。 CAHDR 和 MCWC 是 TN 艾滋病研究中心 (TN-CFAR) 的一部分，该中心是一个多机构协作中心，涉及 范德比尔特大学医学中心 (VUMC)、MMC、田纳西州卫生部和纳什维尔 CARES。 此外，我们的长期合作伙伴关系也丰富了我们的艾滋病毒/艾滋病研究和培训环境 通过 Meharry Vanderbilt Alliance (MVA) 与 VUMC 合作。因此，拟议的艾滋病毒/艾滋病研究和 培训设施将使我们能够进一步利用现有的合作伙伴关系，成为以下领域的全球领导者： 艾滋病毒/艾滋病健康差异研究和培训。目前，只有四个物理实验室 位于 CAHDR 内，其他几名艾滋病毒/艾滋病调查员则居住在其他建筑物内。这个物理 我们的艾滋病毒/艾滋病调查人员之间的分离对互动、培训、接触和合作造成了障碍。 此外，我们目前缺乏现代化和尖端的实验室空间和设施，严重阻碍了我们的研究。 吸引新教师加入 CAHDR 的能力。为了解决这些差距，本提案概述了 毗邻 CAHDR 的尖端艾滋病毒/艾滋病实验室设施，将包括可容纳四到六个新人的空间 研究人员在开放的实验室空间格式中。总之，这项改造提案将提供前所未有的 有机会将所有梅哈里艾滋病毒/艾滋病研究人员带到 CAHDR 楼层并扩大我们的艾滋病毒/艾滋病研究 计划进入尖端新领域。最重要的是，现代和尖端的艾滋病毒研究空间将 允许我们准备并增加代表性不足的少数族裔 (URM) 和黑人、原住民和 有色人种 (BIPOC) 研究人员参与以艾滋病毒为重点的研究。